...
首页> 外文期刊>Saudi journal of kidney diseases and transplantation : >Encapsulating peritoneal sclerosis with steroid-resistant massive ascites successfully treated by peritoneal lavage
【24h】

Encapsulating peritoneal sclerosis with steroid-resistant massive ascites successfully treated by peritoneal lavage

机译:用腹膜灌洗成功治疗类固醇抗大规模腹水包封腹膜硬化

获取原文
           

摘要

Encapsulating peritoneal sclerosis (EPS) is the most serious complication of long-term peritoneal dialysis (PD). EPS is diagnosed by clinical symptoms (abdominal pain, nausea, vomiting, diarrhea, and anorexia.) and image study (intestinal expansion, peritoneal thickening and calcification, and ascites.). Steroid therapy and surgery are recommended as the treatment of EPS. Here, we report a case of EPS with steroid-resistant massive ascites successfully treated with peritoneal lavage. A 59-year-old female with end-stage kidney disease secondary to hypertension was started on PD in 2003. Due to recurrent exit-site infection and two episodes of peritonitis, she was transferred to hemodialysis (HD), and her PD catheter was removed in 2011. In February 2012, six months after discontinuation of PD, she was found to have massive ascites on abdominal computerized tomography (CT). The patient was diagnosed to have EPS and was started on prednisolone. Despite eight months of prednisolone therapy, the ascites did not decrease. Therefore, the PD catheter was inserted again, and she was started on daily peritoneal lavage from September 2012. After four months of daily peritoneal lavage, her ascites disappeared in January 2013. The PD catheter was removed in July 2013. Steroid treatment was completed in May 2014, and there has been no recurrence of ascites since then. The evaluation of ascites by abdominal CT is important in a patient on long-term PD. Since EPS may appear any time after the discontinuation of PD, it is important to start screening abdominal CT shortly after the discontinuation of PD. Steroid-resistant massive ascites can be successfully treated with peritoneal lavage.
机译:包封腹膜硬化症(EPS)是长期腹膜透析(PD)的最严重并发症。 EPS被临床症状(腹痛,恶心,呕吐,腹泻和厌食症。)和图像研究(肠道膨胀,腹膜增厚和钙化和腹水。)。适用于EPS的治疗类固醇治疗和手术。在这里,我们报告了用腹膜灌洗成功治疗的类固醇抗性腹水的EPS案例。在2003年的PD上启动了一名59岁的女性患有高血压的末期肾脏疾病。由于经常出现的出位感染和两发作腹膜炎,她被转移到血液透析(HD),而她的PD导管是在2011年删除。2012年2月,在停止PD后六个月,她被发现在腹部电脑断层扫描(CT)上有巨大的腹水。患者被诊断为EPS并开始在泼尼松龙。尽管持续了8个月的泼尼松龙治疗,腹水没有减少。因此,PD导管再次插入,她于2012年9月开始于每日腹膜灌洗。每日四个月的腹膜灌洗后,她的腹水在2013年1月消失。PD导管于2013年7月被删除。固醇治疗完成从2014年5月,从那时起,腹水没有复发。通过腹部CT对长期PD的患者进行评估。由于EPS可能出现在停止PD后的任何时间,因此在停止PD后不久开始筛选腹部CT。耐腹膜灌洗可以成功治疗类固醇型腹水。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号